DSM has been producing high-quality ingredients for the food, feed and
pharmaceutical industries for more than 100 years. Many of these products are
made by biotechnological methods. Biotechnology at DSM amounts to
approximately Euro 1.5 bn in sales (2008)
DSM's use of biotechnology is confined to specific, carefully selected
micro-organisms: bacteria, yeasts and fungi.
White Biotechnology will have a fundamental impact on the future of the
chemical industry, and in enabling society to respond to the challenges of
climate change, resource and energy scarcity.
As the leader in White Biotechnology DSM is ideally positioned to take
advantage of the opportunities that exist around this technology.
DSM organizes round table events to educate stakeholders on the importance of
biotechnology for people, planet and profit. The latest round table event was
held in Amsterdam and London, for media and analysts.
